Market Report of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market

 


Chronic inflammatory demyelinating polyneuropathy (CIDP) is a peripheral nerve system autoimmune condition characterized by arm and leg weakness and reduced sensory function. Damage to the myelin sheath, a fatty covering that covers and protects nerve fibers, causes this illness. Nerves cause muscle contractions and send sensory information to the brain via the spinal cord. Myelin works as an insulator, allowing electrical impulses to travel freely across nerve fibers. The immune system damages or destroys myelin in CIDP patients, causing nerve fibers to degenerate. This causes loss or weakening of electrical impulses in the arms and legs, resulting in weakness or loss of sensation. CIDP can strike people of any age and gender.

Market Growth

The global prevalence rate of Chronic Inflammatory Demyelinating Polyneuropathy Treatment Market (CIDP) is increasing as the number of new instances of CIDP rises and there is no permanent cure available. CIDP affects about 40,000 individuals in the United States at any given time, according to the American Association of Neuromuscular & Electrodiagnostic Medicine. Over the next few years, the rising prevalence rate is predicted to increase demand for CIDP treatment. Growing research in the field of CIDP therapy is likely to result in the development of new medications, which will drive up demand for CIDP treatment medications over the projected period. There are now 38 ongoing clinical trials for CIDP treatment, according to clinicaltrials.gov. GBS/CIDP Foundation Worldwide, for example, focuses on raising awareness about CIDP and related conditions by offering support to patients, their families, and careers, as well as developing national and international support groups. Revenue growth is likely to be fueled by public awareness and support activities.

Market Segment

The CIDP treatment market is divided into two categories: therapy type and geography. The global CIDP therapy market is divided into three types of treatments: corticosteroids, intravenous immunoglobulin, and plasmapheresis (plasma exchange). In addition to the major treatment approaches, physicians may use treatments such as chemotherapy and physiotherapy to strengthen the muscles. When first treatments fail or have negative side effects on the patient's health, subsequent treatments are usually selected.

Baxter International Inc., Kedrion S.p.A, Octapharma AG, CSL Behring, Grifols, S.A., and others are some of the major players in the CIDP therapy industry.

Market Insight

The study's varied insights are based on extensive cycles of primary and secondary research conducted by the analysts throughout the research process. TMR's analysts and professional advisers use industry-wide, quantitative customer insights tools and market prediction methodology to produce trustworthy results. The report not only provides estimates and projections, but also a clear assessment of these statistics in terms of market dynamics. For business owners, CXOs, policymakers, and investors, these insights combine a data-driven research approach with qualitative consultations. The information will also assist their clients in overcoming their concerns.

Comments

Post a Comment

Popular posts from this blog

What is eHealth? What are eHealth software services?

Image
  Electronic health, or e-health, is a broad term that refers to the use of technology, particularly electronic communication, in healthcare settings. The term "eHealth" is often used to characterize health efforts that use the internet to deliver health data, information, or services. Software and services that handle, transmit, store, or record information used in the delivery of healthcare treatment, payment, or record keeping are referred to as eHealth applications. eHealth applications, for example, often use the Internet to transmit and retain patient data for a provider or payer. Doctors, hospitals, and insurance companies utilize these eHealth applications to keep track of their patients' health information. The application of information technology to healthcare is known as HIT. This term refers to the electronic systems used by healthcare professionals (and occasionally patients) to store, share, and analyses health data. It's another term for the coordi...
Read more

In what ways is the market for antistatic agents’ market is expanding?

Image
  Antistatic agents are used to treat materials or their surfaces in order to reduce or eliminate static electricity buildup. By absorbing moisture from the air, antistatic agents make the surface or the material itself slightly conductive, preventing the formation of static charges and preventing dust fixation. Antistatic agents' various benefits, such as reducing electrostatic buildup or improving conductivity, preventing dust and other pollutant attraction, very effective dispersion on films or molded articles, and lowering surface resistivity, are expected to benefit the overall anti-static agent’s industry demand over the forecast period. Market Challenges The packaging and electronics industries generate large amounts of waste that are not only difficult to dispose of but can also have a negative impact on the environment. Plastic pollution on the earth's surface has a negative impact on human life and wildlife habitats. Because plastics decompose slowly, they endange...
Read more

HPV & Pap Testing Market Overview, Scope and Trends

Image
Pap tests (also known as Pap smears) are used to detect cancers and precancers in the cervix. Precancers are changes in cells caused by the human papillomavirus (HPV). If left untreated, these abnormal cells may develop into cervical cancer. An HPV test detects HPV in cervical cells. Market Overview The HPV & Pap testing market was valued at around USD 3,550 million in 2020, and it is expected to reach USD 5,180 million by 2026, growing at a CAGR of 6.5 percent between 2021 and 2026. The market is being driven by an increase in the number of cervical cancer cases worldwide, an increase in the number of cervical cancer screening programmes, and the introduction of a new cervical cancer screening test. With the rising COVID-19 pandemic globally in 2020, various elective medical procedures, including cancer screening, were found to be largely put on hold in order to prioritise other urgent needs and reduce the risk of COVID-19 spread. This has resulted in a significant decrease i...
Read more